Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 020219
Company: NOVARTIS
Company: NOVARTIS
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
LIVOSTIN | LEVOCABASTINE HYDROCHLORIDE | EQ 0.05% BASE | SUSPENSION/DROPS;OPHTHALMIC | Discontinued | None | No | No |